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Abstract
Background
Fetal smoke exposure is a common and key avoidable risk factor for birth complications and
seems to influence later risk of overweight. It is unclear whether this increased risk is also
present if mothers smoke during the first trimester only or reduce the number of cigarettes
during pregnancy, or when only fathers smoke. We aimed to assess the associations of
parental smoking during pregnancy, specifically of quitting or reducing smoking and mater-
nal and paternal smoking combined, with preterm birth, small size for gestational age, and
childhood overweight.
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Methods and findings
We performed an individual participant data meta-analysis among 229,158 families from 28
pregnancy/birth cohorts from Europe and North America. All 28 cohorts had information on
maternal smoking, and 16 also had information on paternal smoking. In total, 22 cohorts were
population-based, with birth years ranging from 1991 to 2015. The mothers’ median age was
30.0 years, and most mothers were medium or highly educated. We used multilevel binary
logistic regression models adjusted for maternal and paternal sociodemographic and lifestyle-
related characteristics. Compared with nonsmoking mothers, maternal first trimester smoking
only was not associated with adverse birth outcomes but was associated with a higher risk of
childhood overweight (odds ratio [OR] 1.17 [95% CI 1.02–1.35], P value = 0.030). Children
from mothers who continued smoking during pregnancy had higher risks of preterm birth (OR
1.08 [95% CI 1.02–1.15], P value = 0.012), small size for gestational age (OR 2.15 [95% CI
2.07–2.23], P value < 0.001), and childhood overweight (OR 1.42 [95% CI 1.35–1.48], P
value < 0.001). Mothers who reduced the number of cigarettes between the first and third tri-
mester, without quitting, still had a higher risk of small size for gestational age. However, the
corresponding risk estimates were smaller than for women who continued the same amount
of cigarettes throughout pregnancy (OR 1.89 [95% CI 1.52–2.34] instead of OR 2.20 [95% CI
2.02–2.42] when reducing from 5–9 to�4 cigarettes/day; OR 2.79 [95% CI 2.39–3.25] and
OR 1.93 [95% CI 1.46–2.57] instead of OR 2.95 [95% CI 2.75–3.15] when reducing from�10
to 5–9 and�4 cigarettes/day, respectively [P values < 0.001]). Reducing the number of ciga-
rettes during pregnancy did not affect the risks of preterm birth and childhood overweight.
Among nonsmoking mothers, paternal smoking was associated with childhood overweight
(OR 1.21 [95% CI 1.16–1.27], P value < 0.001) but not with adverse birth outcomes. Limita-
tions of this study include the self-report of parental smoking information and the possibility of
residual confounding. As this study only included participants from Europe and North Amer-
ica, results need to be carefully interpreted regarding other populations.
Conclusions
We observed that as compared to nonsmoking during pregnancy, quitting smoking in the first
trimester is associated with the same risk of preterm birth and small size for gestational age,
but with a higher risk of childhood overweight. Reducing the number of cigarettes, without quit-
ting, has limited beneficial effects. Paternal smoking seems to be associated, independently of
maternal smoking, with the risk of childhood overweight. Population strategies should focus on
parental smoking prevention before or at the start, rather than during, pregnancy.
Author summary
Why was this study done?
• Maternal smoking during pregnancy is an important risk factor for various birth com-
plications and childhood overweight.
• It is not clear whether this increased risk is also present if mothers smoke during the
first trimester only or reduce the number of cigarettes during pregnancy.
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• The associations of paternal smoking with birth and childhood outcomes also remain
unknown.
What did the researchers do and find?
• We conducted an individual participant data meta-analysis using data from 229,158
families from 28 pregnancy and birth cohorts from Europe and North America to assess
the associations of parental smoking during pregnancy, specifically of quitting or reduc-
ing smoking and maternal and paternal smoking combined, with preterm birth, small
size for gestational age, and childhood overweight.
• We observed that smoking in the first trimester only did not increase the risk of preterm
birth and small size for gestational age but was associated with a higher risk of childhood
overweight, as compared to nonsmoking. Reducing the number of cigarettes during
pregnancy, without quitting, was still associated with higher risks of these adverse
outcomes.
• Paternal smoking seems to be associated, independently of maternal smoking, with the
risks of childhood overweight.
What do these findings mean?
• Population strategies should focus on parental smoking prevention before or at the start
of, rather than during, pregnancy.
• Future studies are needed to assess the specific associations of smoking in the precon-
ception and childhood periods with offspring outcomes.
Introduction
One in five women of reproductive age are expected to be tobacco users by 2025 [1]. Although
strategies to prevent smoking are globally implemented, up to 25% of women in Western
countries smoke during pregnancy [2]. This is a major public health concern, particularly
since smoking during pregnancy not only affects women’s own health but is also associated
with adverse birth and offspring outcomes, such as preterm birth, low birth weight, and child-
hood overweight [3–13]. Preterm birth and low birth weight are major causes of perinatal
morbidity and mortality, and childhood overweight is related to a higher risk of cardiovascular
disease, premature death, and disability in adulthood [14–16].
A vast number of studies observed consistent associations of continued maternal smoking
during pregnancy with increased risks of preterm birth, low birth weight, and childhood over-
weight [7,10,11]. However, evidence on critical windows of vulnerability to maternal smoking
and changes in smoking behavior during pregnancy remain inconclusive, potentially reflecting
between-study heterogeneity of outcome measures and small study sample sizes. Previous
studies focusing on maternal smoking in first trimester of pregnancy only consistently showed
no associations with preterm birth but showed conflicting results for the risks of low birth
weight and childhood overweight [8,9,17–21]. Also, the associations of paternal smoking dur-
ing pregnancy with preterm birth, low birth weight, and childhood overweight have been
PLOS MEDICINE Parental smoking and birth and offspring outcomes
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scarcely studied and remain unclear [20,22,23]. Paternal smoking might affect offspring out-
comes through direct gamete or passive smoking intrauterine effects. However, comparisons
of maternal and paternal smoking associations can also be used to disentangle direct uterine
programming effects and confounding by shared or family-based lifestyle or socioeconomic
variables. To our knowledge, no large sample size studies assessed the associations of maternal
smoking during first trimester only, of reducing the number of cigarettes during pregnancy, or
of paternal smoking only with birth and childhood outcomes.
We conducted an individual participant data meta-analysis among 229,158 singleton births
from 28 pregnancy and birth cohort studies in Europe and North America to assess the associ-
ations of parental smoking during pregnancy with preterm birth, small size for gestational age
(SGA), and childhood overweight. We were specifically interested in the associations of quit-
ting or reducing smoking during pregnancy and of combined maternal and paternal smoking
patterns with birth and offspring outcomes.
Methods
Inclusion criteria and participating cohorts
This study was part of an international LifeCycle Project (https://lifecycle-project.eu) collabo-
ration on maternal obesity and childhood outcomes [24–28]. Pregnancy and birth cohort stud-
ies were eligible for inclusion if they included mothers with singleton live-born children who
were born from 1989 onwards, had information available on maternal prepregnancy/early-
pregnancy body mass index (BMI), and had at least one offspring measurement (birth weight
or childhood BMI). We identified eligible cohorts from existing collaborations on childhood
health (EarlyNutrition Project, CHICOS Project, www.birthcohorts.net assessed until July
2014). Fifty cohorts from Europe, North America, and Oceania were identified and invited, of
which 39 cohorts agreed to participate. The cohorts were approved by their local institutional
review boards, and written informed consent from all participants or parents was obtained.
Eleven cohorts were excluded from the current analysis because there was no information on
maternal smoking patterns or only nonsmoking mothers in their cohort. In total, 28 cohorts
comprising data on 229,158 singleton births were included (Fig 1). Twenty-two of the 28
cohorts defined themselves as regionally or nationally based studies, four as hospital-based
(Co.N.ER, EDEN, GASPII, LUKAS), one as internet users–based (NINFEA), and one as study-
ing selected populations (FCOU). The plan for analyses given to the cohorts when inviting
them to participate in this paper from the LifeCycle Project collaboration is provided in S1
Text. Based on data availability and additional research questions, it was decided among the
collaborators to refine the existing questions and to extend the project with additional ques-
tions to be addressed. Analyses that were not in the original plan are marked in S1 Text. Asso-
ciations of smoking with early- and late-childhood BMI were excluded because of low
numbers. All cohorts provided written informed consent for using their data. Anonymized
datasets were stored on a single central secured data server with access for the main analysts
(EP, SS) only. This study is reported according to the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) guideline (S1 PRISMA Checklist).
Parental tobacco smoking
Parental smoking information was obtained by questionnaires (cohort-specific information in
S1 Table). We used trimester-specific maternal smoking information to categorize smoking
during pregnancy in three groups (nonsmoking; first-trimester-only smoking; continued
smoking [as being any second or third trimester smoking]). Trimester-specific maternal
smoking information was categorized into nonsmoking,�4 cigarettes/day, 5–9 cigarettes/day,
PLOS MEDICINE Parental smoking and birth and offspring outcomes
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and�10 cigarettes/day. We combined the information about maternal smoking in first and
third trimester to examine the change in smoking behavior. Information on paternal non-
smoking/smoking was used. To explore the combined effects of maternal and paternal smok-
ing, we combined the maternal and paternal smoking information into six categories:
maternal and paternal nonsmoking (used as reference category); maternal nonsmoking and
paternal smoking; maternal first-trimester-only smoking and paternal nonsmoking; maternal
first-trimester-only smoking and paternal smoking; maternal continued smoking and paternal
nonsmoking; and maternal continued smoking and paternal smoking.
Birth complications and childhood overweight
Information on gestational age at birth, birth weight, and childhood weight and height was
measured, derived from clinical records, or reported (cohort-specific information in S1
Table). Preterm birth was defined as<37 weeks of gestation, and full-term birth (�37 weeks)
was used as the reference group in the analyses [29]. We created sex- and gestational age–
adjusted birth weight standard deviation scores (SDSs) based on a North European reference
chart [30]. SGA at birth was defined per cohort as sex- and gestational age–adjusted birth
weight below the 10th percentile. The reference group used in the analyses comprises children
born at appropriate and large size for gestational age (i.e., cohort-specific sex- and gestational
age–adjusted birth weight above the 10th percentile). BMI measurements in mid-childhood
(�5 to<10 years) were used. If there were multiple measurements of a child available within
Fig 1. Flowchart of the cohorts and participants. BMI, body mass index.
https://doi.org/10.1371/journal.pmed.1003182.g001
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the age interval, we used the measurement at the highest age. We created sex- and age-adjusted
SDSs of childhood BMI using World Health Organization (WHO) reference growth charts
(Growth Analyzer 4.0, Dutch Growth Research Foundation) [31,32]. Childhood normal
weight, overweight, and obesity were defined using WHO cutoffs [31,32]. For the analyses, we
combined the overweight and obesity group, hereafter referred to as the overweight group.
Normal weight was used as the reference group in childhood overweight analyses.
Covariates
Information on covariates was mostly assessed using questionnaires. Most covariates were
provided by cohorts as categorical variables: child’s sex, maternal educational level (low,
medium, high), parity (nulliparous, multiparous), and alcohol consumption during pregnancy
(yes, no). To allow handling of missing data, continuous covariates were categorized: maternal
age (defined on the basis of data availability: <25.0 years, 25.0–29.9 years, 30.0–34.9 years, and
�35.0 years) and prepregnancy or early-pregnancy maternal and paternal BMI (underweight
[<18.5 kg/m2], normal weight [18.5–24.9 kg/m2], overweight [25.0–29.9 kg/m2], and obesity
[�30.0 kg/m2]). Maternal ethnicity was not included, since most cohorts were largely of Euro-
pean descent and there was a high percentage of missing data. Covariates per cohort are
described in S2 Table.
Statistical analysis
We conducted 1-stage meta-analyses, in which we analyzed individual participant data from
all cohorts simultaneously in binary logistic multilevel mixed-effects models, accounting for
clustering of participants within cohorts [33]. First, we examined the associations of maternal
smoking (across different trimesters; dose-response) with the risks of preterm birth, SGA, and
childhood overweight. When examining the dose-response effects of first trimester maternal
smoking, mothers who continued smoking were excluded from the analysis. Second, we used
similar models to investigate the associations of change in maternal smoking behavior from
first to third trimester with the risks of preterm birth, SGA, and childhood overweight. Finally,
we used similar models to investigate the combined associations of both maternal and paternal
smoking with the risks of these outcomes. We assessed whether the risk estimates between cat-
egories statistically differed using the formula Z ¼ b1  b2ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
ðSEb1Þ2þðSEb2Þ2
p [34]. We adjusted all analyses
focused on maternal smoking for maternal age, educational level, parity, prepregnancy or
early-pregnancy BMI, alcohol consumption during pregnancy, and paternal smoking. We
adjusted all analyses focused on combined maternal and paternal smoking for the same covari-
ates and paternal BMI. As sensitivity analyses, we repeated all models for gestational age at
birth, sex- and gestational age–adjusted birth weight SDSs, and childhood sex- and age-
adjusted BMI SDSs. Also, we conducted two-stage random-effects meta-analyses for the core
associations and tested for heterogeneity between the cohorts estimates with the I2 test [33,35].
To express the uncertainty associated with I2 estimates, we calculated the corresponding 95%
confidence intervals (CIs) [36]. All covariates were categorized and missing values were added
as an additional group to prevent exclusion of noncomplete cases. If information on a covari-
ate was available for less than 50% of the cohort sample used for each analysis, available infor-
mation was not used and the corresponding data for that full cohort sample were assigned to
the missing category. We conducted a sensitivity analysis with complete cases only. Also, to
explore the influence on our results of using maternal age and BMI as categorical covariates,
we repeated the complete cases’ analysis using these covariates continuously. The statistical
analyses were performed using the Statistical Package of Social Sciences version 24.0 for
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Windows (SPSS, Chicago, IL, United States of America) and Review Manager (RevMan) ver-
sion 5.3 of the Cochrane Collaboration (The Nordic Cochrane Centre, Copenhagen,
Denmark).
Results
Participants’ characteristics
Information about the main characteristics per cohort is given in Table 1. Overall, 14.4%
(range 5.5–26.8) of mothers and 27.5% (range 16.9–83.8) of fathers smoked during pregnancy.
Children were born at a median gestational age of 40.0 weeks (95% range 35.7–42.3) and a
median birth weight of 3,530 grams (95% range 2,390–4,580). In total, 4.7% of children were
born preterm, 10.0% were SGA at birth, and 20% were in the overweight group. Additional
information about maternal smoking is given in S3 Table.
Changes in maternal smoking habits during pregnancy and the risks of
preterm birth, SGA, and childhood overweight
Table 2 shows that maternal first trimester smoking only was not associated with adverse birth
outcomes but was associated with higher risks of childhood overweight (odds ratio [OR] 1.17
(95% CI 1.02–1.35), P value = 0.030). Compared with children from mothers who did not
smoke during pregnancy, those from mothers who continued smoking had higher risks of pre-
term birth (OR 1.08 [1.02–1.15], P value = 0.012), SGA (OR 2.15 [2.07–2.33], P value< 0.001),
and childhood overweight (OR 1.42 [1.35–1.48], P value < 0.001). We observed dose-response
relationships for third trimester smoking starting at�4 cigarettes/day. We observed similar
results when we used the continuous outcomes, except for the association of first-trimester-
only smoking with childhood BMI SDS, which was in the same direction but no longer signifi-
cant (S4 Table). We observed similar results when using two-stage random-effects models
(Figs 2, 3 and 4). We observed low to moderate heterogeneity between the cohorts’ estimates
(I2 estimates range from 0% to 47%; corresponding CIs are presented in the footnotes of Figs
2, 3 and 4). Only the cohort-specific results for the associations of maternal continued smoking
with SGA showed high heterogeneity between estimates (I2 75% [95% CI 56%–86%]). Almost
all cohorts were included in the analyses for continued smoking, whereas only roughly half
had information on first-trimester-only smoking. When restricting the two-stage continued
smoking models to the cohorts also with information on first-trimester-only smoking, we
observed a lower heterogeneity between estimates (I2 23% [95% CI 0%–65%]), but the pooled
risk estimate remained similar (S1 Fig).
Table 3 shows that, compared with mothers who did not smoke during pregnancy, mothers
who quit smoking from first to third trimester had similar risks of delivering SGA infants.
Reducing the number of cigarettes, without quitting, from first to third trimester lowered the
risks of delivering SGA infants, but risks were still higher compared with those of nonsmoking
mothers (OR 1.89 [1.52–2.34] when reducing from 5–9 to�4 cigarettes/day; 2.79 [2.39–3.25]
and 1.93 [1.46–2.57] when reducing from�10 to 5–9 and� 4 cigarettes/day, respectively [all
P values< 0.001]). Mothers who increased the number of cigarettes from first to third trimes-
ter increased their risks of delivering SGA infants (OR 2.43 [2.05–2.89] and 2.47 [1.71–3.58]
when increasing from�4 to 5–9 and�10 cigarettes/day, respectively; and 2.70 [2.35–3.10]
when increasing from 5–9 to�10 cigarettes/day [all P value < 0.001]). Changes in maternal
smoking from first to third trimester did not influence the risks of preterm birth and child-
hood overweight. Similar results were observed when assessing the associations of the changes
in maternal smoking during pregnancy with the continuous outcomes (S5 Table).
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Table 1. Characteristics of the participating pregnancy and birth cohorts (n = 229,158).
Maternal smoking Paternal smoking Birth outcomes Childhood BMI
Cohort name,
number of
participants, birth
years (country)
No First
trimester
only
Continued No Yes Gestational
age at birth
(weeks)
Preterm
birth
Birth
weight
(g)
Small size for
gestational
age at birth
Age
(months)
BMI
(SDS)
Overweight
ABCD, n = 7,324,
2003–2004 (the
Netherlands)
6,571
(89.7)
NA 753 (10.3) NA NA 40.0 (35.0–
42.0)
385 (5.3) 3,460
(2,270–
4,500)
732 (10.1) 68.1
(61.6–
82.1)
0.09
(−1.69
to 2.29)
706 (16.6)
ALSPAC,
n = 12,148, 1991–
1992 (United
Kingdom)
9,581
(78.9)
NA 2,567
(21.1)
7,397
(63.2)
4,301
(36.8)
40.0 (35.0–
42.0)
650 (5.4) 3,440
(2,240–
4,420)
1,190 (10.0) 115.0
(88.0–
119.0)
0.24
(−1.61
to 2.66)
1,960 (26.3)
BAMSE, n = 4,057,
1994–1996
(Sweden)
3,533
(87.1)
72 (1.8) 452 (11.1) 2,756
(83.1)
560
(16.9)
40.0 (35.0–
42.0)
212 (5.3) 3,545
(2,334–
4,550)
396 (9.9) 101.0
(89.0–
109.0)
0.52
(−1.20
to 2.63)
814 (31.2)
BIB, n = 1,641,
2007–2010 (UK)
1,398
(85.2)
NA 243 (14.8) NA NA 39.7 (35.3–
41.9)
83 (5.1) 3,200
(2,180–
4,280)
163 (10.0) NA NA NA
Co.N.ER, n = 641,
2004–2005 (Italy)
549
(85.6)
30 (4.7) 62 (9.7) 441
(68.9)
199
(31.1)
39.0 (36.0–
41.0)
29 (4.5) 3,340
(2,420–
4,230)
63 (9.9) 95.0
(86.6–
111.1)
0.69
(−1.29
to 2.92)
102 (35.5)
DNBC, n = 71,710,
1996–2002
(Denmark)
59,030
(82.3)
NA 12,680
(17.7)
49,534
(70.5)
20,756
(29.5)
40.1 (35.9–
42.4)
3,168
(4.4)
3,600
(2,420–
4,640)
7,124 (10.0) 85.0
(75.1–
89.5)
0.01
(−1.95
to 2.07)
5,644 (15.5)
EDEN, n = 1,880,
2003–2005
(France)
1,376
(73.2)
148 (7.9) 356 (18.9) 999
(59.5)
679
(40.5)
39.0 (35.0–
41.0)
106 (5.6) 3,300
(2,158–
4,200)
187 (10.0) 67.6
(65.0–
72.4)
−0.01
(−1.52
to 2.02)
145 (12.9)
FCOU, n = 4,003,
1993–1996
(Ukraine)
3,647
(91.1)
NA 356 (8.9) 461
(16.2)
2,382
(83.8)
NA NA 3,400
(2,100–
4,300)
393 (10.2) 84.0
(75.0–
93.0)
−0.02
(−2.02
to 2.06)
119 (12.7)
GASPII, n = 680,
2003–2004 (Italy)
599
(88.1)
23 (3.4) 58 (8.5) 510
(75.2)
168
(24.8)
40.0 (36.0–
42.0)
28 (4.1) 3,350
(2,401–
4,320)
67 (9.9) 104.0
(98.0–
113.0)
0.70
(−1.37
to 2.66)
172 (37.1)
GENERATION R,
n = 7,934, 2002–
2006 (The
Netherlands)
6,190
(78.0)
461 (5.8) 1,283
(16.2)
2,833
(56.5)
2,183
(43.5)
40.1 (35.4–
42.3)
474 (6.0) 3,420
(2,190–
4,480)
788 (10.0) 115.3
(69.4–
119.4)
0.35
(−1.52
to 2.67)
1,578 (27.1)
GENERATION
XXI, n = 7,541,
2005–2006
(Portugal)
5,766
(76.5)
540 (7.2) 1,235
(16.4)
NA NA 39.0 (35.0–
41.0)
557 (7.4) 3,200
(2,130–
4,095)
747 (10.0) 85.0
(70.2–
95.0)
0.63
(−1.38
to 3.23)
1,991 (37.9)
GENESIS,
n = 2,261, 2003–
2004 (Greece)
1,842
(81.5)
30 (1.3) 389 (17.2) NA NA 40.0 (34.0–
40.0)
224
(10.0)
3,250
(2,100–
4,200)
213 (10.0) 61.9
(60.1–
71.9)
0.93
(−1.43
to 4.11)
39 (43.3)
GINIplus,
n = 2,086, 1995–
1998 (Germany)
1,903
(91.2)
NA 193 (8.8) NA NA NA NA NA NA 62.9
(60.2–
74.4)
0.01
(−1.77
to 1.93)
215 (10.3)
HUMIS, n = 986,
2002–2009
(Norway)
932
(94.5)
NA 54 (5.5) NA NA 40.1 (33.2–
42.9)
86 (8.7) 3,580
(1,822–
4,703)
98 (10.0) 84.0
(60.0–
92.0)
0.02
(−2.03
to 2.14)
58 (17.5)
INMA, n = 2,406,
1997–2008 (Spain)
1,988
(82.6)
NA 418 (17.4) 1,395
(58.0)
1,009
(42.0)
39.9 (36.0–
42.0)
98 (4.1) 3,250
(2,300–
4,200)
238 (10.0) 83.6
(75.1–
94.5)
0.55
(−1.37
to 3.31)
489 (37.7)
KOALA, n = 2,800,
2000–2002 (the
Netherlands)
2,594
(92.6)
NA 206 (7.4) NA NA 40.0 (36.0–
42.0)
89 (3.2) 3,500
(2,478–
4,510)
277 (10.0) 106.2
(61.5–
119.3)
−0.17
(−2.16
to 1.77)
199 (11.4)
(Continued)
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Table 1. (Continued)
Maternal smoking Paternal smoking Birth outcomes Childhood BMI
Cohort name,
number of
participants, birth
years (country)
No First
trimester
only
Continued No Yes Gestational
age at birth
(weeks)
Preterm
birth
Birth
weight
(g)
Small size for
gestational
age at birth
Age
(months)
BMI
(SDS)
Overweight
LISAplus,
n = 1,965, 1997–
1999 (Germany)
1,697
(86.4)
87 (4.4) 181 (9.2) 1,557
(82.0)
342
(18.0)
NA NA NA NA 62.7
(60.2–
74.0)
−0.09
(−1.92
to 1.88)
201 (10.2)
LUKAS, n = 441,
2002–2005
(Finland)
371
(84.1)
35 (7.9) 35 (7.9) NA NA NA NA 3,630
(2,790–
4,689)
44 (10.0) 73.2
(68.6–
76.0)
0.52
(−1.08
to 3.33)
114 (31.4)
MoBa, n = 80,116,
1999–2009
(Norway)
72,466
(90.5)
NA 7,650 (9.5) 63,071
(79.2)
16,523
(20.8)
40.1 (36.1–
42.4)
3,312
(4.1)
3,620
(2,521–
4,640)
7,967 (10.0) 85.9
(61.0–
100.9)
0.15
(−2.05
to 2.30)
6,002 (19.5)
NINFEA,
n = 2,259, 2005–
2010 (Italy)a
2,085
(92.3)
29 (1.3) 145 (6.4) NA NA 39.7 (35.9–
41.9)
91 (4.0) 3,240
(2,271–
4,189)
220 (10.0) 86.1
(84.8–
93.1)
−0.02
(−2.16
to 2.43)
95 (21.5)
PE´LAGIE,
n = 1,353, 2002–
2005 (France)
1,022
(75.2)
172 (12.7) 159 (11.8) 597
(61.8)
369
(38.2)
40.0 (36.0–
41.0)
44 (3.3) 3,400
(2,460–
4,315)
135 (10.0) NA NA NA
Piccolipiu`,
n = 3,292, 2011–
2015 (Italy)
2,572
(78.1)
374 (11.4) 346 (10.5) 1,496
(71.4)
598
(28.6)
39.0 (36.0–
41.0)
93 (2.9) 3,340
(2,470–
4,229)
323 (10.0) NA NA NA
PRIDE Study,
n = 1,616, 2011–
2015 (the
Netherlands)
1,519
(94.0)
39 (2.4) 58 (3.6) NA NA 39.0 (35.6–
41.0)
77 (4.9) 3,484
(2,280–
4,500)
154 (9.9) NA NA NA
Project Viva,
n = 2,001, 1999–
2002 (USA)
1,784
(89.2)
124 (6.2) 93 (4.6) NA NA 39.7 (34.7–
41.9)
142 (7.1) 3,487
(2,155–
4,536)
199 (10.0) 92.2
(82.5–
116.5)
0.42
(−1.38
to 3.04)
315 (30.6)
REPRO_PL,
n = 1,434, 2007–
2011 (Poland)
1,215
(84.7)
83 (5.8) 136 (9.5) 866
(63.0)
509
(37.0)
39.0 (36.0–
41.0)
64 (4.5) 3,350
(2,376–
4,290)
142 (10.0) 88.0
(84.3–
94.0)
0.64
(−1.55
to 3.64)
19 (38.8)
RHEA, n = 651,
2007–2008
(Greece)
544
(83.6)
NA 107 (16.4) 287
(48.6)
303
(51.4)
38.0 (35.0–
40.0)
73 (11.3) 3,190
(2,312–
4,059)
63 (9.9) NA NA NA
SCOPE
BASELINE,
n = 1,216, 2009–
2011 (Ireland)
1,078
(88.7)
NA 138 (11.3) 739
(78.5)
203
(21.5)
40.3 (35.2–
41.7)
60 (4.9) 3,460
(2,353–
4,485)
121 (10.0) NA NA NA
SWS, n = 2,716,
1998–2007 (UK)
2,316
(85.3)
NA 400 (14.7) NA NA 40.1 (35.1–
42.1)
154 (5.7) 3,450
(2,330–
4,475)
268 (10.0) 80.3
(74.7–
87.2)
0.21
(−1.51
to 2.47)
368 (22.0)
Total group 196,168
(85.6)
2,247 (1.0) 30,743
(13.4)
134,939
(72.5)
51,084
(27.5)
40.0 (35.7–
42.3)
10,299
(4.7)
3,530
(2,390–
4,580)
22,312 (10.0) 85.2
(61.0–
117.7)
0.13
(−1.86
to 2.43)
21,345
(20.0)
Values are expressed as number of participants (valid %) or medians (95% range). “First trimester only” refers to mothers who smoked during first trimester only.
Childhood overweight also includes obesity and includes information at child age�5 to <10 years. Preterm birth is defined as birth before the gestational age of 37
weeks. Small size for gestational age is defined as the lowest 10% of sex- and gestational age–adjusted birth weight SDS per cohort.
a Subset of participants with follow-up completed at 4 years of child’s age by the time of data transfer (March 2015).
Abbreviations: BMI, body mass index; NA, not available (not collected or not provided) or not applicable (gestational age at birth [FCOU, GINIplus, LISAplus, LUKAS]
and birth weight [GINIplus, LISAplus] due to study samples restricted to specific ranges of gestational age and weight at birth); SDS, standard deviation score
https://doi.org/10.1371/journal.pmed.1003182.t001
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Parental smoking during pregnancy and the risks of preterm birth, SGA,
and childhood overweight
Among mothers who did not smoke during pregnancy, paternal smoking tended to be associ-
ated with higher risks of preterm birth (OR 1.06 [1.00–1.12], P value = 0.05), SGA (OR 1.04
[1.00–1.09], P value = 0.05), and childhood overweight (OR 1.21 [1.16–1.27], P value < 0.001)
(Table 4). Among mothers who smoked during first trimester only, paternal smoking was not
associated with preterm birth or SGA but was associated with a higher risk of childhood over-
weight (OR 1.36 [1.02–1.80], P value = 0.036). Among mothers who continued smoking dur-
ing pregnancy, paternal smoking further increased the risks of SGA and childhood overweight
(both Z-score P value for differences in effect sizes between categories <0.0001) but not the
risk of preterm birth. Children whose mothers continued smoking during pregnancy and
whose fathers also smoked had the highest risks of being born preterm (OR 1.10 [1.02–1.19], P
value = 0.016) and SGA (OR 2.37 [2.26–2.49], P value < 0.001) and of childhood overweight
(OR 1.76 [1.65–1.87], P value< 0.001). Similar results were observed for the combined mater-
nal and paternal smoking with the continuous outcomes (S6 Table).
Table 2. Maternal smoking with risks of birth complications and childhood overweight.
Maternal smoking Preterm birth Small size for gestational age at birth Childhood overweight
Odds ratio (95% confidence interval) Odds ratio (95% confidence interval) Odds ratio (95% confidence interval)
No maternal smoking Reference Reference Reference
ncases/total = 8,586/188,357 ncases/total = 16,879/190,873 ncases/total = 17,530/92,434
Only first trimester smoking 1.03 (0.85–1.25) 0.99 (0.85–1.15) 1.17 (1.02–1.35)�
ncases/total = 120/2,116 ncases/total = 200/2,144 ncases/total = 329/1,084
First trimester dosage
�4 cigarettes/day 0.99 (0.70–1.39) 0.96 (0.75–1.22) 1.02 (0.78–1.33)
ncases/total = 36/828 ncases/total = 77/826 ncases/total = 78/340
5–9 cigarettes/day 1.00 (0.58–1.72) 0.90 (0.59–1.36) 1.37 (0.92–2.06)
ncases/total = 14/288 ncases/total = 25/288 ncases/total = 35/136
�10 cigarettes/day 0.81 (0.45–1.46) 0.88 (0.57–1.35) 1.31 (0.89–1.93)
ncases/total = 12/273 ncases/total = 23/271 ncases/total = 40/152
Continued smoking 1.08 (1.02–1.15)� 2.15 (2.07–2.23)�� 1.42 (1.35–1.48)��
ncases/total = 1,593/29,951 ncases/total = 5,233/30,125 ncases/total = 3,486/13,083
Continued smoking dosage
�4 cigarettes/day 1.01 (0.89–1.14) 1.57 (1.45–1.70)�� 1.30 (1.18–1.42)��
ncases/total = 288/5,866 ncases/total = 836/6,034 ncases/total = 688/2,792
5–9 cigarettes/day 1.07 (0.95–1.19) 2.40 (2.25–2.56)�� 1.42 (1.30–1.55)��
ncases/total = 367/7,115 ncases/total = 1,341/7,162 ncases/total = 813/3,284
�10 cigarettes/day 1.11 (1.01–1.22)� 2.93 (2.76–3.10)�� 1.55 (1.43–1.67)��
ncases/total = 524/9,771 ncases/total = 2,001/9,743 ncases/total = 1,137/4,139
Values are odds ratios (95% confidence intervals) from multilevel binary logistic mixed-effects models that reflect the risk of preterm birth, small size for gestational age,
and childhood overweight per smoking group compared with the reference group (no maternal smoking).
Number of cigarettes used as continued smoking dosage was based on third trimester information. Preterm birth is defined as birth before the gestational age of 37
weeks. Small size for gestational age is defined as the lowest 10% of sex- and gestational age–adjusted birth weight standard deviation score per cohort. Childhood
overweight is overweight and obesity together according to the World Health Organization criteria. Models are adjusted for maternal age, educational level, parity,
prepregnancy or early-pregnancy body mass index, alcohol consumption during pregnancy, and paternal smoking.
�P value < 0.05.
��P value < 0.001.
https://doi.org/10.1371/journal.pmed.1003182.t002
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Fig 2. Maternal smoking with risks of preterm birth assessed by 2-stage random-effects models. (A) First trimester smoking versus nonsmoking, (B) continued
smoking versus nonsmoking. Values are odds ratios (95% CIs) per cohort and pooled from binary logistic regression models that reflect the risk of preterm birth per
smoking pattern (first-trimester-only smoking or continued smoking) compared to that of nonsmoking. Models are adjusted for maternal age, educational level, parity,
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Discussion
In this study, maternal continued smoking during pregnancy was associated, in a dose-
response manner, to higher risks of preterm birth, being SGA at birth, and childhood over-
weight. Maternal smoking during the first trimester of pregnancy only was not associated with
risks of preterm birth and SGA but was associated with a higher risk of childhood overweight.
Reducing the number of cigarettes during pregnancy without quitting may be beneficial for
the risk of SGA but seems not to influence the risks of preterm birth and childhood over-
weight. Paternal smoking seems to be associated, independently of maternal smoking, with the
risks of childhood overweight.
Maternal smoking is a major public health concern [1]. The associations of maternal con-
tinued smoking during pregnancy and increased risks of preterm birth and SGA are well
established [7,10,18]. Also, several studies have suggested associations of fetal smoke exposure
with childhood overweight and obesity [11,22]. In line with these previous studies, we
observed that children whose mothers continued smoking during pregnancy have higher risks
of preterm birth, being SGA at birth, and overweight in childhood. The risks of preterm birth
were somewhat weaker than reported previously [7,9,18], potentially because no information
was available about induced or spontaneous preterm birth.
Results from previous studies focused on the associations of maternal early smoking cessa-
tion and of reducing the number of cigarettes during pregnancy with child health outcomes
are inconsistent [8,17,19,21,22]. Results from prospective studies in the Netherlands and Aus-
tralia previously suggested that quitting smoking after the first trimester was not associated
with risks of adverse birth outcomes [18,19]. A large US study with more than 21,000 first tri-
mester smokers reported that smoking of any duration during pregnancy was associated with
an increased risk of fetal growth restriction with decreasing risk the earlier that cessation
occurred [17]. Similarly, a recent study from the UK Millennium Cohort Study suggested that
two-thirds of the total adverse smoking impact on birth weight occurs in the second trimester
and that cutting smoking intensity by the third month in pregnancy leads to infants of the
same weight as those infants born to persistent light smokers [37]. A recent study investigating
associations of parental smoking with fetal growth using additional methods of mendelian ran-
domization and parental negative control showed consistent linear dose-dependent associa-
tions of maternal smoking with fetal growth from early second trimester onward [38]. These
studies suggest that smoking cessation programs should focus on the benefit of quitting as
early in pregnancy as possible. A previous analysis using data from the Nurses’ Health Study
showed that first-trimester-only maternal smoking was not, or was only to a limited extent,
associated with obesity in later life [20]. However, in the same cohort, first-trimester-only
maternal smoking was associated with type 2 diabetes in the offspring [39]. In the current
study, maternal first-trimester-only smoking was not associated with the risks of preterm birth
or SGA but was associated with an increased risk of childhood overweight. A biological expla-
nation might be that maternal first-trimester-only smoking already leads to specific adapta-
tions, which might have lifelong consequences for body composition and metabolic health in
later life, but the fetal smoke exposure is not long enough to affect birth outcomes. Reducing
the number of cigarettes from first to third trimester lowered the risks of SGA, but risks were
still elevated compared with those in infants born to nonsmoking mothers. This association
was not observed for preterm birth and childhood overweight. Thus, our findings suggest that
prepregnancy or early-pregnancy body mass index, alcohol consumption during pregnancy, and paternal smoking. The cohorts for which no estimate was provided had
no data available for that particular analysis. The heterogeneity between the estimates of each cohort was 0% (95% CI 0%–57%) and 4% (95% CI 0%–47%) for first-
trimester-only smoking and continued smoking, respectively. CI, confidence interval, IV, instrumental variable.
https://doi.org/10.1371/journal.pmed.1003182.g002
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Fig 3. Maternal smoking with risks of small size for gestational age assessed by two-stage random-effects models. (A) First trimester smoking versus nonsmoking,
(B) continued smoking versus nonsmoking. Values are odds ratios (95% CIs) per cohort and pooled from binary logistic regression models that reflect the risk of small
size for gestational age per smoking pattern (first-trimester-only smoking or continued smoking) compared to that of nonsmoking. Models are adjusted for maternal
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quitting smoking in the first trimester of pregnancy might optimize birth outcomes but might
not reduce the risk of adverse metabolic effects in the offspring to the level of nonsmoking.
Also, reducing the number of cigarettes from first trimester onward may reduce risks of fetal
growth restriction.
The role of paternal smoking during pregnancy on child health outcomes remains unclear
[23,40,41]. Paternal smoking has been associated with reduced semen quality and fertility and
higher risks of spontaneous abortion, birth defects, and, in the long-term, attention-deficit/
hyperactivity disorder and several cancers [42–45]. A recent meta-analysis showed that pater-
nal smoking was associated with increased risks of preterm birth and SGA [44]. In a previous
Dutch study, paternal smoking during pregnancy among nonsmoking mothers was associated
with higher childhood BMI [12]. A small study from the US using self-reported smoking and
serum cotinine measurements found a higher BMI at 2 and 3 years of age in children whose
mothers were exposed to passive smoking during pregnancy [40]. In the current study, pater-
nal smoking among nonsmoking mothers was associated with a higher risk of childhood over-
weight and tended to be associated with higher risks of preterm birth and SGA. This suggests
that paternal smoking may be, independently of maternal smoking, associated with childhood
overweight. However, we cannot exclude the possibility of residual confounding by factors not
or insufficiently measured in the studies. Previous studies used comparisons of maternal and
paternal smoking associations to explore potential mechanisms [12,46]. In the current study, if
only one parent smoked, the risks of SGA were much higher among maternal smokers than
among paternal smokers, whereas the risks of preterm birth for maternal and paternal smok-
ing were similar. The similar associations of maternal and paternal smoking and preterm birth
may suggest that the underlying mechanisms include shared family-based characteristics, such
as environmental exposures and lifestyle. The stronger associations of maternal smoking, com-
pared with paternal smoking, with SGA may suggest that these associations are mainly
explained by intrauterine mechanisms. Since paternal smoking among nonsmoking mothers
was not associated with SGA, the risk increase when both parents smoked may represent an
additional mechanistic pathway through shared family-based characteristics. The risk of over-
weight was slightly higher among children whose mothers smoked than whose fathers smoked.
However, the risks increased significantly if both parents smoked. These findings suggest that,
although intrauterine programming mechanisms might play a role, shared family-based life-
style and genetic characteristics are potential underlying mechanisms. Whether these findings
also reflect transgenerational epigenetic inheritance through the gametes needs to be further
studied.
Various components of tobacco smoke might be involved in the mechanistic pathway
toward adverse birth outcomes and childhood overweight. Both nicotine and carbon monox-
ide are reported to reduce placental blood flow [47]. Nicotine stimulates acetylcholine recep-
tors, which release a multitude of vasoactive catecholamines and peptides, which in turn
reduce blood flow through vasoconstriction [47]. Carbon monoxide competes with oxygen for
binding sites on the transport protein hemoglobin, causing hypoxia [48]. Chronic hypoxia
interferes with the maternal circulatory adjustments to pregnancy which can be another cause
of reduced placental blood flow [49]. Uterine blood flow is essential for uterine, placental, and
fetal growth. Several mechanisms for nicotine-induced alterations in overweight risks have
been proposed, including stimulation of the fetal hypothalamic-pituitary axis [50]. It has been
age, educational level, parity, prepregnancy or early-pregnancy body mass index, alcohol consumption during pregnancy, and paternal smoking. The cohorts for which
no estimate was provided had no data available for that particular analysis. The heterogeneity between the estimates of each cohort was 21% (95% CI 0%–65%) and 75%
(95% CI 56%–86%) for first-trimester-only smoking and continued smoking, respectively. CI, confidence interval, IV, instrumental variable.
https://doi.org/10.1371/journal.pmed.1003182.g003
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Fig 4. Maternal smoking with risks of childhood overweight assessed by two-stage random-effects models. (A) First trimester smoking versus nonsmoking, (B)
continued smoking versus nonsmoking. Values are odds ratios (95% CIs) per cohort and pooled from binary logistic regression models that reflect the risk of childhood
overweight per smoking pattern (first-trimester-only smoking or continued smoking) compared to that of nonsmoking. Models are adjusted for maternal age,
educational level, parity, prepregnancy or early-pregnancy body mass index, alcohol consumption during pregnancy, and paternal smoking. The cohorts for which no
estimate was provided had no data available for that particular analysis. The heterogeneity between the estimates of each cohort was 0% (95% CI 0%–60%) and 47%
(95% CI 1%–72%) for first-trimester-only smoking and continued smoking, respectively. CI, confidence interval, IV, instrumental variable.
https://doi.org/10.1371/journal.pmed.1003182.g004
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Table 3. Change in maternal smoking habits during pregnancy and risks of birth complications and childhood
overweight.
Maternal smoking Preterm birth Small size for gestational
age at birth
Childhood overweight
Odds ratio (95%
confidence interval)
Odds ratio (95%
confidence interval)
Odds ratio (95%
confidence interval)
No maternal smoking in
first trimester
Third trimester no
smoking
Reference Reference Reference
ncases/total = 4,527/100,634 ncases/total = 8,698/103,740 ncases/total = 11,177/59,070
Third trimester�4
cigarettes/day
0.73 (0.40–1.34) 1.20 (0.81–1.78) 1.31 (0.90–1.92)
ncases/total = 11/278 ncases/total = 28/274 ncases/total = 41/147
Third trimester 5–9
cigarettes/day
1.07 (0.48–2.48) 2.02 (1.18–3.46)� 1.27 (0.64–2.37)
ncases/total = 6/104 ncases/total = 16/103 ncases/total = 13/51
Third trimester�10
cigarettes/day
1.51 (0.65–3.49) 1.74 (0.91–3.32) 1.60 (0.72–3.55)
ncases/total = 6/80 ncases/total = 11/79 ncases/total = 10/31
Maternal smoking in first
trimester�4 cigarettes/
day
Third trimester quit 0.96 (0.69–1.35) 1.04 (0.82–1.31) 1.20 (0.94–1.53)
ncases/total = 38/862 ncases/total = 84/859 ncases/total = 98/388
Third trimester�4
cigarettes/day
1.05 (0.86–1.27) 1.54 (1.37–1.74)�� 1.32 (1.14–1.52)��
ncases/total = 114/2,261 ncases/total = 328/2,457 ncases/total = 289/1,169
Third trimester 5–9
cigarettes/day
1.15 (0.85–1.55) 2.43 (2.05–2.89)�� 1.81 (1.45–2.25)��
ncases/total = 47/885 ncases/total = 170/880 ncases/total = 121/440
Third trimester�10
cigarettes/day
1.37 (0.76–2.47) 2.47 (1.71–3.58)�� 1.31 (0.79–2.19)
ncases/total = 12/186 ncases/total = 36/185 ncases/total = 21/86
Maternal smoking in first
trimester 5–9 cigarettes/
day
Third trimester quit 1.04 (0.62–1.73) 0.95 (0.64–1.42) 1.32 (0.91–1.92)
ncases/total = 16/304 ncases/total = 27/304 ncases/total = 41/165
Third trimester�4
cigarettes/day
0.86 (0.58–1.28) 1.89 (1.52–2.34)�� 1.53 (1.17–2.00)�
ncases/total = 27/657 ncases/total = 102/654 ncases/total = 80/307
Third trimester 5–9
cigarettes/day
1.00 (0.85–1.18) 2.21 (2.02–2.42)�� 1.43 (1.26–1.61)��
ncases/total = 163/3,551 ncases/total = 630/3,617 ncases/total = 403/1,704
Third trimester�10
cigarettes/day
0.99 (0.76–1.30) 2.70 (2.35–3.10)�� 1.40 (1.15–1.69)�
ncases/total = 59/1,330 ncases/total = 265/1,319 ncases/total = 149/632
Maternal smoking in first
trimester�10 cigarettes/
day
Third trimester quit 0.82 (0.46–1.43) 1.06 (0.71–1.57) 1.34 (0.96–1.88)
ncases/total = 13/285 ncases/total = 28/283 ncases/total = 52/194
Third trimester�4
cigarettes/day
1.26 (0.82–1.95) 1.93 (1.46–2.57)�� 1.14 (0.81–1.61)
ncases/total = 22/358 ncases/total = 59/354 ncases/total = 48/192
Third trimester 5–9
cigarettes/day
1.26 (0.97–1.63) 2.79 (2.39–3.25)�� 1.46 (1.18–1.80)��
ncases/total = 62/1,078 ncases/total = 224/1,072 ncases/total = 128/503
(Continued)
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suggested that cadmium, present in tobacco smoke, modulates oxytocin receptor function,
proposing a role in the pathophysiology of preterm birth [48]. Recent studies have found an
association between maternal smoking during pregnancy and birth weight with a mediating
role of DNA methylation [51–53]. Further research is needed to assess such possible mecha-
nisms. During the last few years, e-cigarettes have been widely used as substitutes for smoking.
Evidence from recently started cohorts is needed to clarify whether e-cigarettes are any safer
during pregnancy.
We performed an individual participant data meta-analysis of prospective cohort studies to
investigate the associations of parental smoking during pregnancy with preterm birth, SGA,
and childhood overweight. We included data from cohort studies in Europe and North Amer-
ica, so our findings are mainly applicable to populations in developed countries. Inclusion of
data from other regions could have led to differences in prevalence of maternal and paternal
smoking, birth complications, childhood overweight, and ethnic and sociodemographic char-
acteristics, complicating or limiting the possibility of doing a meta-analysis. Among study limi-
tations, our outcomes might not be generalizable to populations from low-income and
middle-income countries, which need to be further studied. The large sample size enabled us
to investigate the effects of changing smoking habits and paternal smoking. However, our
study might have been underpowered to detect associations in the analyses looking at mater-
nal-only first trimester smoking and the change in smoking habits from first to third trimester,
due to small sample sizes. Since we used original, individual participant data, we did not for-
mally assess the quality of the individual studies included. We are aware that our study cannot
overcome potential limitations of individual studies in terms of their design and conduct, dif-
ferences in the definitions of exposure and outcome data, and variation in missing data. Paren-
tal smoking information during pregnancy was self-reported. For active smoking, correlations
between cotinine measurements and self-reported smoking habits are high [54]. We have no
information on the specific question asked or the timing in which it was asked, which might
have differed across cohorts and influenced our results. It has been suggested that using mater-
nal nonsmokers as a reference group without considering the impact of passive smoke expo-
sure may contribute to an underestimation of the estimated effects [40]. To limit this
misclassification, all analyses on maternal smoking were adjusted for paternal smoking.
Table 3. (Continued)
Maternal smoking Preterm birth Small size for gestational
age at birth
Childhood overweight
Odds ratio (95%
confidence interval)
Odds ratio (95%
confidence interval)
Odds ratio (95%
confidence interval)
Third trimester�10
cigarettes/day
1.16 (1.04–1.31)� 2.95 (2.75–3.15)�� 1.67 (1.53–1.83)��
ncases/total = 364/6,949 ncases/total = 1,434/6,940 ncases/total = 849/2,976
Values are odds ratios (95% confidence intervals) from multilevel binary logistic mixed-effects models that reflect the
risk of preterm birth, small size for gestational age, and childhood overweight per change in smoking group
compared with that of the reference group (nonsmoking in first and third trimester). Preterm birth is defined as
birth before the gestational age of 37 weeks. Small size for gestational age is defined as the lowest 10% of sex- and
gestational age–adjusted birth weight standard deviation score per cohort. Childhood overweight is overweight and
obesity together according to the World Health Organization criteria. Models are adjusted for maternal age,
educational level, parity, prepregnancy body mass index, alcohol consumption during pregnancy, and paternal
smoking.
�P value < 0.05.
��P value < 0.001.
https://doi.org/10.1371/journal.pmed.1003182.t003
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Although smoking in the preconception period has been reported not to be associated with
fetal growth restriction, studies considering its effect on childhood overweight are lacking
[17]. In the current study, information on smoking in the preconception period was missing.
Further research is needed to assess the associations of smoking in the preconception period
with offspring outcomes. It has been suggested that exposure to smoking during childhood
amplifies the association between prenatal smoke exposure and childhood BMI outcomes
[55]. Many women resume smoking shortly after birth. Six weeks after birth, approximately
25% of women resumed smoking, and 1 year after birth these numbers are up to 80% [56]. In
our study, information on exposure to smoking during childhood was not available for most
cohorts. Further research is needed to assess whether childhood BMI outcomes are addition-
ally influenced by exposure to smoking during childhood. Overall, we observed low to moder-
ate heterogeneity in the 2-stage random-effects models, which might be due to the inclusion of
cohorts that were mostly high-income and of European descent. However, we observed high
heterogeneity between the cohorts for the associations of maternal continued smoking with
SGA. This might be in part explained by differences in pattern and dosage of maternal and
paternal smoking between cohorts. When we restricted the 2-stage continued smoking models
to the cohorts that also had information on first-trimester-only smoking, we observed a sub-
stantially lower heterogeneity between estimates. Missing values of covariates were used as an
additional group. This approach has been commonly used in large meta-analyses of individual
participant data because of the constraints in applying more advanced imputation strategies.
Although we cannot disregard the possibility of bias, we consider it unlikely considering the
relatively small percentage of missing data [57]. We observed similar results when we
Table 4. Associations of maternal and paternal smoking with risks of birth complications and childhood overweight.
Maternal and paternal smoking Preterm birth Small size for gestational age at birth Childhood overweight
Odds ratio (95% confidence interval) Odds ratio (95% confidence interval) Odds ratio (95% confidence interval)
Maternal nonsmoking
Paternal nonsmoking Reference Reference Reference
ncases/total = 5,232/123,666 ncases/total = 10,746/123,328 ncases/total = 10,298/59,395
Paternal smoking 1.06 (1.00–1.12) 1.04 (1.00–1.09) 1.21 (1.16–1.27)��
ncases/total = 1,505/31,890 ncases/total = 3,030/33,691 ncases/total = 3,199/15,474
Maternal first trimester smoking
Paternal nonsmoking 0.64 (0.36–1.15) 0.78 (0.53–1.13) 1.36 (0.98–1.87)
ncases/total = 12/412 ncases/total = 30/412 ncases/total = 54/233
Paternal smoking 1.03 (0.70–1.51) 1.05 (0.80–1.39) 1.36 (1.02–1.80)�
ncases/total = 29/626 ncases/total = 59/625 ncases/total = 70/305
Maternal continued smoking
Paternal nonsmoking 1.04 (0.93–1.15) 2.06 (1.94–2.20)�� 1.33 (1.23–1.44)��
ncases/total = 405/8,768 ncases/total = 1,366/8,723 ncases/total = 877/3,872
Paternal smoking 1.10 (1.02–1.19)� 2.37 (2.26–2.49)�� 1.76 (1.65–1.87)��
ncases/total = 810/15,806 ncases/total = 2,896/15,967 ncases/total = 1,785/6,661
Values are odds ratios (95% confidence intervals) from multilevel binary logistic mixed-effects models that reflect the risk of preterm birth, small size for gestational age,
and childhood overweight per smoking group compared with the reference group (no parental smoking).
Preterm birth is defined as birth before the gestational age of 37 weeks. Small size for gestational age is defined as the lowest 10% of sex- and gestational age–adjusted
birth weight standard deviation score per cohort. Childhood overweight is overweight and obesity together according to the World Health Organization criteria. Models
are adjusted for maternal age, maternal body mass index, paternal body mass index, maternal education, parity, and maternal alcohol consumption during pregnancy.
�P value < 0.05.
��P value < 0.001.
https://doi.org/10.1371/journal.pmed.1003182.t004
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conducted a complete case analysis (S7 Table). Also, similar associations were observed when
adjusting for maternal age and BMI as categorical or continuous covariates (S7 and S8 Tables).
Although we adjusted for multiple lifestyle-related factors, we cannot exclude residual con-
founding by other environmental lifestyle-related factors. From the current observational data,
no conclusions can be drawn on the causality of the observed associations.
Our results suggest that as compared to mothers who continued smoking throughout preg-
nancy, mothers who quit smoking during the first trimester have a reduced risk of birth com-
plications. Reducing the number of cigarettes without quitting during pregnancy is still
associated with an increased risk of birth complications. The observed risk estimates were
small to moderate but are important from a public health perspective, since smoking is a com-
mon adverse exposure and preterm birth and SGA are among the most frequent birth compli-
cations. Also, preterm birth, SGA, and childhood obesity are related with adverse health
consequences later in life. Our findings suggest that it is of great importance to invest in pre-
vention of smoking in women of reproductive age before or at the start of pregnancy. Pregnant
women should still be motivated to reduce smoking, even later in pregnancy. The current
guidelines focus only on quitting smoking and not reducing, which can be discouraging for
women who find it difficult to quit smoking. These women should be provided with sufficient
information about the risks of continued smoking but also about the benefits of reducing their
number of cigarettes. Future research should investigate whether quitting smoking in the first
trimester or reducing the number of cigarettes during pregnancy is also beneficial for other
adverse birth and offspring outcomes. Although we cannot exclude a role of residual con-
founding and shared family-based characteristics in the associations of paternal smoking with
childhood overweight, we recommend that fathers are more closely involved in preconception
and pregnancy consultations focused on smoking reduction.
Our results suggest that maternal smoking during the first trimester only is not associated
with the risks of SGA and preterm birth but is associated with a higher risk of childhood over-
weight. Reducing the number of cigarettes during pregnancy without quitting may be benefi-
cial for the risk of SGA but does not influence the risks of preterm birth and childhood
overweight. Paternal smoking seems to be associated, independently of maternal smoking,
with the risks of childhood overweight. Population strategies should focus on parental smok-
ing prevention before or at the start of, rather than during, pregnancy.
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